Risks for bleeding in patients with pulmonary embolism treated with thrombolytic agents.
Hogness
C
C
D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012107:Research Design; D012307:Risk Factors
D005343:Fibrinolytic Agents